Santé & Pharma

Liquidia Corp

8B

LivaNova PLC

4,2B

Lixte Biotechnology Holdings, INC.

125,4M

LogicMark, Inc.

2,3B

Longeveron Inc.

24,2M

Longeveron Inc.

19,1M

Lonza Group AG

Lotus Eye Hospital and Institute Limited

2,4B

Lucid Diagnostics Inc.

180,3M

Lucira Health, Inc.

Lumito AB (publ)

Lumito AB (publ)

Lumito AB (publikt)

Lumito AB (publikt)

Lumos Diagnostics Holdings Limited

118,1M

Lumos Pharma, INC.

Lupin Limited

1,1T

Lyell Immunopharma, Inc.

360,5M

Lyka Labs Limited

2,2B

Lyra Therapeutics, Inc.

603,5k

Lytix Biopharma ASA

653,7M

MAAT PHARMA

54,4M

MABION S.A.

120,4M

MAIA Biotechnology, Inc.

86,3M

MANNKIND CORP

1,3B

MAPS MAPS GROUP: IN THE FIRST HALF, STRONG GROWTH IN PRODUCTS DRIVEN BY THE HEALTHCARE SECTOR. CUSTOM PROJECTS RECORD A DECLINE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

35,3M

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

MARIA ISABEL LOZANO FERNANDEZ

MARIMED INC.

27,2M

MASI AGRICOLA MASI AGRICOLA - C.S. ASSEMBLEA STRAORDINARIA DEL 04.03.2024

MASIMO CORP

9,4B

MBK Wellness Holdings株式会社

MEDICINOVA INC

66M

MEDIFAST INC

141,1M

MEDINCELL

931,5M

MEDNAX, INC.

2,2B

MEDNAX, INC.

2,2B

MEI Pharma, Inc.

MERCK Kommanditgesellschaft auf Aktien

58,4B

MISONIX INC

MOLOGEN Lifescience AG

MPH Health Care AG

103,2M

MPM Corpóreos S.A.

MSP Recovery, Inc.

MYOMO, INC.

56,2M

Mabwell (Shanghai) Bioscience Co., Ltd. - B

10,2B

Macrogenics INC

288,6M

Madrigal Pharmaceuticals, INC.

11,8B

Magellan Health INC